This is a community-generated profile. If you would like to claim it, please .
Endochoice Funding
$0
44 rounds
Endochoice is active in the following markets / industries: biotechnology and health care. The company has secured funding across 4 rounds and is valued at $0. Their most recent funding was raised on January 4, 2013.
Funding Rounds
U
$43000000U
$4500000U
$7800000U
$3200000Investors of Endochoice
Accelmed
Hazim Ansari
CEO at Novel IP
Experienced healthcare, real estate, and start-up investor, mentor, and coach.
We help the daring build legendary companies
Rounds
U
